1. Home
  2. TBI vs ELTX Comparison

TBI vs ELTX Comparison

Compare TBI & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrueBlue Inc.

TBI

TrueBlue Inc.

HOLD

Current Price

$6.63

Market Cap

205.5M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$13.26

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBI
ELTX
Founded
1985
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.5M
185.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
TBI
ELTX
Price
$6.63
$13.26
Analyst Decision
Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$18.00
AVG Volume (30 Days)
300.4K
136.0K
Earning Date
05-05-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
61.39
39.29
EPS
N/A
N/A
Revenue
N/A
$2,301,000.00
Revenue This Year
$6.25
N/A
Revenue Next Year
$3.90
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.18
$7.37
52 Week High
$7.78
$14.97

Technical Indicators

Market Signals
Indicator
TBI
ELTX
Relative Strength Index (RSI) 67.05 61.18
Support Level $5.44 $9.76
Resistance Level $6.61 $14.41
Average True Range (ATR) 0.40 1.07
MACD 0.05 0.37
Stochastic Oscillator 71.96 67.89

Price Performance

Historical Comparison
TBI
ELTX

About TBI TrueBlue Inc.

TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: